Stay updated on Troriluzole Adjunct in OCD: Efficacy & Safety Clinical Trial
Sign up to get notified when there's something new on the Troriluzole Adjunct in OCD: Efficacy & Safety Clinical Trial page.

Latest updates to the Troriluzole Adjunct in OCD: Efficacy & Safety Clinical Trial page
- Check5 days agoChange DetectedNew screenshot shows a UI refresh of the Record History page with the same list of version entries, and underlying trial data appear unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check12 days agoNo Change Detected
- Check33 days agoChange DetectedMajor update: page now includes a government funding status notice and indicates version 3.2.0, replacing the previous 3.1.0.SummaryDifference8%

- Check41 days agoChange DetectedVersion updated from v3.0.2 to v3.1.0; no other content changes detected.SummaryDifference0.2%

- Check55 days agoChange DetectedVersion updated from v3.0.1 to v3.0.2; 'Back to Top' element removed. Overall, no meaningful changes to core content, pricing, stock, or time-sensitive information.SummaryDifference0.5%

- Check62 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content or other important elements.SummaryDifference0.5%

- Check69 days agoChange DetectedThe web page has added a facility name and location details, while removing specific state, country, and city information. This indicates a shift towards a more generalized presentation of location data.SummaryDifference67%

Stay in the know with updates to Troriluzole Adjunct in OCD: Efficacy & Safety Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Troriluzole Adjunct in OCD: Efficacy & Safety Clinical Trial page.